Alzheimer's drug aducanumab not approved for use in EU Charities are disappointed but regulators say there is still little evidence of the drug's benefit.
|
2026. Május 21. Konstantin napja van
2026. Május 21. Konstantin napja van
Alzheimer's drug aducanumab not approved for use in EU Charities are disappointed but regulators say there is still little evidence of the drug's benefit.
|
